Friday, June 12

Browsing: HER2CLIMB05

Support

138 HER2CLIMB-05: A Randomized, Double-blind, Phase 3 Study of Tucatinib Versus Placebo Added to Trastuzumab and Pertuzumab as Maintenance Therapy for HER2+ Metastatic Breast Cancer

By NewsCancerMay 2, 20260

BackgroundHyperglycemia is an on-target, off-tumor effect of PI3K/AKT pathway inhibitors, including capivasertib and alpelisib, used in the treatment of hormone…

► Necessary Cookies Always Active

Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.

► Functional Cookies Remark

Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.

► Analytical Cookies Remark

Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.

► Advertisement Cookies Remark

Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.

What's Hot

Hair treatment 'brought my sparkle back' after cancer

Mes/Stem-A ovarian cancer subtypes predict sensitivity to ATR inhibition

73 The ADC Era in Breast Cancer: Contemporary Sequencing Strategies and Evidence-Based Toxicity Management

Browsing: HER2CLIMB05

138 HER2CLIMB-05: A Randomized, Double-blind, Phase 3 Study of Tucatinib Versus Placebo Added to Trastuzumab and Pertuzumab as Maintenance Therapy for HER2+ Metastatic Breast Cancer

Hair treatment 'brought my sparkle back' after cancer

Mes/Stem-A ovarian cancer subtypes predict sensitivity to ATR inhibition

73 The ADC Era in Breast Cancer: Contemporary Sequencing Strategies and Evidence-Based Toxicity Management

Woman who has endured three cancers completes 141-hill challenge

Hair treatment 'brought my sparkle back' after cancer

Mes/Stem-A ovarian cancer subtypes predict sensitivity to ATR inhibition

73 The ADC Era in Breast Cancer: Contemporary Sequencing Strategies and Evidence-Based Toxicity Management

Woman who has endured three cancers completes 141-hill challenge

Latest Post

Hair treatment 'brought my sparkle back' after cancer

Mes/Stem-A ovarian cancer subtypes predict sensitivity to ATR inhibition

73 The ADC Era in Breast Cancer: Contemporary Sequencing Strategies and Evidence-Based Toxicity Management

Subscribe to Updates

What's Hot

Browsing: HER2CLIMB05